Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

1,450.00INR
2:49pm IST
Change (% chg)

Rs17.00 (+1.19%)
Prev Close
Rs1,433.00
Open
Rs1,331.40
Day's High
Rs1,470.00
Day's Low
Rs1,326.45
Volume
3,802,070
Avg. Vol
1,825,270
52-wk High
Rs2,000.00
52-wk Low
Rs545.00

WCKH.NS

Chart for WCKH.NS

About

Wockhardt Limited is an India-based pharmaceutical and biotechnology company. The Company also owns a chain of advanced super speciality hospitals. The Company offers treatment regimens for cardiology, neurosurgery, orthopaedics, critical care, oncology, nephrology and urology. The Company has filed ANDA applications for its... (more)

Overall

Beta: 0.64
Market Cap(Mil.): Rs157,734.50
Shares Outstanding(Mil.): 110.07
Dividend: 20.00
Yield (%): 1.74

Financials

  WCKH.NS Industry Sector
P/E (TTM): 35.69 35.92 38.01
EPS (TTM): 40.15 -- --
ROI: -- 16.11 15.44
ROE: -- 16.90 16.48
Search Stocks

Wockhardt hopes to resolve FDA ban on two plants in FY16

MUMBAI - Generic drugmaker Wockhardt hopes to resolve all concerns raised by the U.S. Food and Drug Administration (FDA) over manufacturing practices at two of its plants in the current financial year, its chairman said on Friday.

1:53pm IST

India's Wockhardt hopes to resolve FDA ban on two plants in FY2016

MUMBAI, May 29 - Indian generic drugmaker Wockhardt hopes to resolve all concerns raised by the U.S. Food and Drug Administration (FDA) over manufacturing practices at two of its plants in the current financial year, its chairman said on Friday.

1:49pm IST

BRIEF-India Wockhardt exec: hope to resolve FDA concerns about Chikalthana, Waluj plants in current FY

* Exec says hopes to come up with early FDA resolutions for Chikalthana and Waluj plants in western india

10:34am IST

BUZZ-India's Wockhardt gains; Citigroup upgrades to 'buy'

** Citigroup upgrades stock to "buy" from "sell"; increases price target to 1,880 rupees from 1,010 rupees

09 Feb 2015

Earnings vs. Estimates

Search Stocks